G. Standen

发表

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.

P. Vyas, A. Mead, T. Enver, 2011, Cancer cell.

Human Rh D Monoclonal Antibodies (BRAD-3 and BRAD-5) Cause Accelerated Clearance of Rh D+ Red Blood Cells and Suppression of Rh D Immunization in Rh D- Volunteers

M. Goodrick, D. Anstee, G. Standen, 1995 .

Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.

M. Goodrick, D. Anstee, G. Standen, 1995, Blood.

Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation.

S. Ellard, L. Harries, G. Standen, 2007, The Journal of molecular diagnostics : JMD.

Preliminary Observations on Possible Premalignant Changes in Bone Marrow Adjacent to Worn Total Hip Arthroplasty Implants

C. Case, I. Learmonth, R. Howell, 1996, Clinical orthopaedics and related research.

RT‐PCR permits simultaneous genotyping of thiopurine S‐methyltransferase allelic variants by multiplex induced heteroduplex analysis

J. Bidwell, G. Standen, A. Fraser, 2004, Human mutation.

DVT following oral contraceptive therapy in association with homozygous factor V Leiden.

S. Aslam, G. Standen, C. Morse, 2008, Clinical and laboratory haematology.

Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes

P. Vyas, M. Drayson, C. Craddock, 2009, Haematologica.

Wiskott-Aldrich syndrome: no evidence of chromosome instability.

G. Standen, P. Thompson, 1993, Cancer genetics and cytogenetics.

Structural analysis of a missense mutation (Val414Phe) in the catalytic core domain of the factor XIIIA subunit

V. Yee, G. Standen, S. Narayanan, 1997, British journal of haematology.

Rapid detection of MPL Baltimore using LightCycler® technology and melting curve analysis

T. Clench, G. Standen, 2008, British journal of haematology.

An Investigation of the Association of the Prothrombin G20210A Gene Mutation and Inflammatory Bowel Disease: Factor II and IBD

C. Probert, G. Standen, N. Haslam, 2001, Inflammatory bowel diseases.

An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease.

C. Probert, G. Standen, N. Haslam, 1999, European journal of gastroenterology & hepatology.

Idiopathic hypereosinophilic syndrome associated with cutaneous infarction and deep venous thrombosis

G. Standen, J. Pawade, S. Narayan, 2003, The British journal of dermatology.

Activated Protein C Resistance, Factor V Leiden and Peripheral Vascular Disease

G. Standen, C. Irvine, R. Baird, 1997 .

Activated protein C resistance, factor V Leiden and peripheral vascular disease.

G. Standen, C. Irvine, R. Baird, 1997, Cardiovascular surgery.

Postmortem diagnosis of Factor V Leiden from paraffin wax embedded tissue

G. Standen, C. Collins, J. Webb, 1996, Clinical molecular pathology.

Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia.

Jeffrey A Jones, R. Barker, G. Standen, 1997, Blood.

Rapid neonatal diagnosis of von Willebrand's disease by use of the polymerase chain reaction

A. Bloom, I. Peake, D. Bowen, 1990, The Lancet.

Rapid diagnosis of asymptomatic hereditary haemochromatosis by detection of the Cys282Tyr mutation in the HLA-H gene.

G. Standen, S. Aslam, 1997, Postgraduate medical journal.

Production of hemopoietic growth factors and γ-interferon by large granular lymphocytes from patients with Tγ lymphocytosis

N. Matthews, G. Standen, P. Baines, 1987 .

Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.

Anthony R. Dallosso, A. Charles, G. Standen, 2012, Cancer genetics.

THE PROLIFERATIVE STATE OF GRANULOCYTIC PROGENITOR CELLS IN HUMAN BLOOD AND MARROW

G. Standen, J. Fletcher, M. Philip, 1980, Cell and tissue kinetics.

Factor XIII ABristol 1: detection of a nonsense mutation (Arg171→+stop codon) in factor XIII A subunit deficiency

D. Bowen, G. Standen, 1993, British journal of haematology.

Correspondence: Heterozygosity for the thiopurine methyltransferase *3A allele in an acute non-lymphoblastic leukaemia patient with delayed marrow regeneration follow

G. Standen, Nigel Wood, 2008 .

Heterozygosity for the thiopurine methyltransferase *3A allele in an acute non-lymphoblastic leukaemia patient with delayed marrow regeneration following H-DAT chemotherapy.

G. Standen, N. Wood, 2001, British journal of haematology.

Acute promyelocytic leukaemia (M3): Relapse with acute myeloblastic leukaemia (M2) and dic(5;17) (q11; p11)

M. Wagstaff, R. Howell, G. Standen, 1995, American journal of hematology.

Autoimmune neutropenia manifesting as recurrent oral ulceration.

C. Scully, G. Standen, S. Porter, 1994, Oral surgery, oral medicine, and oral pathology.

Genetic analysis in a female manifesting haemophilia B.

G. Standen, A. Oakhill, P. Yates, 1994, Postgraduate medical journal.

Gaucher's disease and acquired coagulopathy.

G. Standen, C. Morse, P. Yates, 2008, Clinical and laboratory haematology.

Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.

A. Bloom, I. Peake, D. Bowen, 1990, Blood.

Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual.

D. Mancuso, I. Peake, G. Standen, 1990, Blood.

Family studies in von Willebrand's disease by analysis of restriction fragment length polymorphisms and an intragenic variable number tandem repeat (VNTR) sequence

I. Peake, D. Bowen, P. Bignell, 1990, British journal of haematology.

Evaluation of a new, integral, whole blood filter (RS2000) system for prestorage leucodepletion of SAG‐M red cells

G. Standen, D. Pamphilon, D. Chan, 1996, British journal of haematology.

Prestorage white cell reduction in saline‐adenine‐glucose‐mannitol red cells by use of an integral filter: evaluation of storage values and invivo recovery

M. Goodrick, G. Standen, D. Pamphilon, 1995, Transfusion.

Production of hemopoietic growth factors and gamma-interferon by large granular lymphocytes from patients with T gamma lymphocytosis.

N. Matthews, G. Standen, P. Baines, 1987, International journal of cell cloning.

Diagnosis of sickle-cell disease with a universal heteroduplex generator

G. Standen, J. Hows, N. Wood, 1993, The Lancet.

UHG-based Mutation Screening in Type 2B von Willebrand’s Disease: Detection of a Candidate Mutation Ser547Phe

J. Bidwell, A. Cumming, D. Bowen, 1996, Thrombosis and Haemostasis.

Rapid genotype analysis in type 2B von Willebrand's disease using a universal heteroduplex generator

J. Bidwell, D. Lillicrap, I. Peake, 1995, British journal of haematology.

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

P. Vyas, S. Soneji, T. Seidl, 2005, Blood.

Antenatal and Intrapartum care of a pregnant woman with glycogen storage disease type 1a.

D. Murphy, G. Standen, M. Scrutton, 2005, European journal of obstetrics, gynecology, and reproductive biology.

Wiskott-Aldrich syndrome: a multidisciplinary disease.

G. Standen, 1991, Journal of clinical pathology.

Chronic neutrophilic leukemia and multiple myeloma: An association with λ light chain expression

M. Wagstaff, B. Jasani, G. Standen, 1990, Cancer.

Reduced Number of Peripheral Blood Granulocytic Progenitor Cells in Patients with Down's Syndrome

G. Standen, J. Fletcher, M. Philip, 1979, British journal of haematology.

Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta.

G. Standen, L. Jones, F. Steers, 1993, Journal of clinical pathology.

Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression.

C. Wardrop, M. Wagstaff, B. Jasani, 1990, Cancer.

FAILURE OF CHRONIC-GRANULOCYTIC-LEUKAEMIA LEUCOCYTES TO RELEASE AN INHIBITOR OF GRANULOPOIESIS

G. Standen, J. Fletcher, M. Philip, 1981, The Lancet.

The Effects of Surgical Trauma on Human Granulopoiesis

G. Standen, J. Fletcher, M. Philip, 1980, British journal of haematology.

Wiskott-Aldrich Syndrome: New Perspectives in Pathogenesis and Management

G. Standen, 1988, Journal of the Royal College of Physicians of London.

Transient t(Y;1)(q12;q21) in a patient with Fanconi anemia and myelodysplastic syndrome.

G. Standen, P. Thompson, A. D. Geddes, 1991, Cancer genetics and cytogenetics.

Wiskott-Aldrich syndrome: fatal consequences of splenectomy in an unrecognised attenuated variant.

J. Orchard, G. Standen, R. Hutton, 1990, The British journal of clinical practice.

Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome.

D. Lillicrap, G. Standen, N. Matthews, 1986, The Quarterly journal of medicine.

Factor XIIIA subunit deficiency due to a homozygous 13‐base pair deletion in exon 3 of the A subunit gene

D. Bowen, G. Standen, R. Gialeraki, 1996, American journal of hematology.

Factor XIIIA calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit

V. Yee, M. Poon, D. Bowen, 1995, British journal of haematology.

Molecular Analysis in Factor XIIIA Deficiency

S. Aslam, G. Standen, 1995, Thrombosis and Haemostasis.

Prenatal diagnosis in factor XIII-A deficiency

C. J. Barton, G. Standen, Caroline J Killick, 1999, Archives of disease in childhood. Fetal and neonatal edition.

Rapid mutation screening in type 2A von Willebrand's disease using universal heteroduplex generators

J. Bidwell, G. Standen, C. Mazurier, 1997, British journal of haematology.

Optimisation and properties of a UHG for genotyping of hemoglobins S and C

J. Bidwell, G. Standen, J. Old, 1995, Human mutation.

Type 2N von Willebrand Disease: Rapid Genetic Diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F) – Detection of a Novel Candidate Type 2N Mutation: C2810T (R854W)

J. Bidwell, A. Cumming, S. Keeney, 1998, Thrombosis and Haemostasis.

Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia

P. Woll, P. Vyas, A. Mead, 2010 .

Myelodysplastic syndrome with trisomy 8 in an adolescent with fanconi anaemia and selective igA deficiency

C. Wardrop, G. Standen, B. Jones, 1989, American journal of hematology.

Genetic Diagnosis of Factor V Leiden Using Heteroduplex Technology

J. Bidwell, D. Bowen, G. Standen, 1997, Thrombosis and Haemostasis.

Telomeric associations in a patient with B‐cell prolymphocytic leukaemia

R. Howell, G. Standen, C. Kitchen, 1993, Genes, chromosomes & cancer.

Clinical Trials and Observations

P. Vyas, A. Foli, P. Milani, 2005 .

Primary extramedullary hematopoiesis manifesting as massive bilateral chylothorax.

G. Standen, L. Lang-Lazdunski, J. Pawade, 2005, The Annals of thoracic surgery.

T cell lymphocytosis associated with polymyositis, myasthenia gravis and thymoma.

G. Standen, S. Otton, I. Ormerod, 2000, Clinical and laboratory haematology.

Pathology of the spleen in large granular lymphocyte leukaemia.

B. Jasani, G. Standen, D. Griffiths, 1989, Journal of clinical pathology.

Molecular analysis of six factor xiii‐a‐deficient families in southern pakistan

S. Aslam, G. Standen, F. Bilwani, 2000, British journal of haematology.

Effect of daily administration of cytotoxic drugs on the erythroid and granulocytic repopulating ability of rat bone marrow.

G. Standen, N. Blackett, 1980, Acta haematologica.

Genetic detection of factor V Leiden: the question of specificity.

D. Bowen, G. Standen, 1997, British journal of haematology.

DNA heteroduplex technology.

J. Bidwell, A. Chrambach, L. Tyfield, 1994 .

Cutaneous presentation of steroid responsive blastoid natural killer cell lymphoma

C. Kennedy, G. Standen, J. Pawade, 2000, British Journal of Dermatology.

METHODS optimisation and Properties of a BIpI[G for ing of Wemogkd3iws s and c

J. Bidwell, G. Standen, J. Old, 2005 .

Should we monitor vitamin B12 levels in patients who have had end-ileostomy for inflammatory bowel disease?

R. Mountford, C. Probert, G. Standen, 2004, International Journal of Colorectal Disease.

A novel insertion mutation (1286insC) in exon 9 of the factor XIII-A subunit gene.

G. Standen, T. Mandalaki, R. Gialeraki, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Rapid detection of MPL Baltimore using LightCycler® technology and melting curve analysis

T. Clench, G. Standen, 2008, British journal of haematology.